Genome Web Breaking News
- MGI Tech Receives China NMPA Approval for DNBSeq-G99 Sequencer
- Top Five Articles on GenomeWeb Last Week: Illumina's New CEO, EDGC Cancer Screening Test, More
- Biocept Licenses CNSide Liquid Biopsy Assay to Plus Therapeutics
- New Products Posted to GenomeWeb: Foundation Medicine, Yourgene Health, Angle
- People in the News at Agilent Technologies, ASHG, Veracyte, Enzo Biochem, Renalytix, More
Stat
- Dianne Feinstein’s struggle with shingles reflects the long increase in cases
- STAT+: Court allows Medicare drug price negotiation to proceed
- STAT+: FDA seeks to regulate lab-developed tests, closing the ‘Theranos loophole’
- STAT+: Unitaid slams J&J over pricing and patents for a tuberculosis drug
- STAT+: Generic makers fall short when providing access to low- and middle-income countries, analysis finds
NYT science news
- A Third of Medicaid Recipients With Opioid Use Disorder Aren’t Getting Medication to Treat It
- FDA Wants to Oversee Lab Tests It Says Put Patients ‘At Risk’
- Most Authors of Major Superconductor Claim Seek Retraction
- A Statue Draped With Snakes? In Italy, It Happens Every Year.
- An Invasive Mosquito Threatens Catastrophe in Africa
Fierce Biotech
- Exo officially enters handheld ultrasound race with launch of AI-powered Iris system
- FDA publishes proposal to increase regulatory oversight of lab-developed tests
- ModeX nets up to $168M in BARDA bucks to develop therapies for viral infections
- Abbott analysis finds FreeStyle Libre CGM and GLP-1 drug adherence rise when used together
- Siemens Healthineers debuts 5-second 3D mammogram machine, new mobile MRI
Fierce Medical Devices
- Exo officially enters handheld ultrasound race with launch of AI-powered Iris system
- FDA publishes proposal to increase regulatory oversight of lab-developed tests
- Abbott analysis finds FreeStyle Libre CGM and GLP-1 drug adherence rise when used together
- Siemens Healthineers debuts 5-second 3D mammogram machine, new mobile MRI
- Revvity rolls out base editing reagents to increase access to preclinical DNA editing tech